… and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a …

… reached a historic milestone— recording data for 10,000 CAR-T therapy patients . This achievement highlights the expanding role and impact of CAR-T therapy in treating haematological malignancies and …

… curative, and novel disease modifying therapies, such as CAR-T cells. Christian Hedrich from University of Liverpool opens … may increase the risk of graft failure and GVHD, while CAR-T cells might offer a cure without immunological …

… the field. A major such new development is the arrival of CAR-T cells, which may turn in a true revolution for the … is making efforts to deliver a roadmap to implement CAR-T programs that overcome potential limitations, secure …

… Multicentric evaluation of CAR-T cell induced pseudoprogression prevalence (PrevCARTiPP) …

… the Implementation and Operational Management of Marketed CAR-T Cell Therapy – submitted for publication. …

… talk us through it. Watch the video The Daily Debate CAR-T Cell Therapy: New Hope for Patients? For our first day’s debate, we focus CAR-T cell therapy, newly approved in the USA and Europe, but …

… of COVID-19 pandemic on nurses: experiences and tips CAR-T Cell and COVID-19 and how and when to restart the … patients with focus on stem cell transplantation and CAR-T cells (EBMT/ASTCT) Strategies to prevent and handle …

… there are 795,972 patients, 913,449 transplants, 15,696 CAR-T treatments, 8,854 Immunosuppressive Treatments and 67 Gene …

… most highly cited articles? Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST … Moiseev et al   Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy®: real-world experience …